✦ LIBER ✦

Detection of centrosome aberrations in disease-unrelated cells from patients with tumor treated with tyrosine kinase inhibitors

✍ Scribed by Michelle Giehl; Armin Leitner; Claudia Haferlach; Peter Duesberg; Wolf-Karsten Hofmann; Ralf Hofheinz; Wolfgang Seifarth; Andreas Hochhaus; Alice Fabarius

Book ID: 114794784
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 293 KB
Volume: 85
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2010.01459.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Emergence of abnormal clone with monsomy

Emergence of abnormal clone with monsomy 7 in Philadelphia negative cells of CML patients treated with tyrosine kinase inhibitors

✍ Monika Ribeiro de Mello Conchon; Israel Bendit; Patricia Ferreira; Walter Lima; 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 154 KB

Are Tyrosine Kinase Inhibitors Still Act

Are Tyrosine Kinase Inhibitors Still Active in Patients With Metastatic Renal Cell Carcinoma Previously Treated With a Tyrosine Kinase Inhibitor and Everolimus? Experience of 36 Patients Treated in France in the RECORD-1 Trial

✍ Blesius, Aurore; Beuselinck, Benoit; Chevreau, Christine; Ravaud, Alain; Rolland 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 303 KB

Early assessment by FDG-PET/CT of patien

Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course

✍ Daiki Ueno, Masahiro Yao, Ukihide Tateishi, Ryogo Minamimoto, Kazuhide Makiyama, 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 321 KB

Levels of circulating CD45dimCD34+VEGFR2

Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors

✍ Farace, F; Gross-Goupil, M; Tournay, E; Taylor, M; Vimond, N; Jacques, N; Billio 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 423 KB

Characterization of skin pathology in no

Characterization of skin pathology in non–small cell lung cancer patients treated with the EGFR tyrosine kinase inhibitor erlotinib

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Risk of thyroid dysfunction in patients

Risk of thyroid dysfunction in patients with solid tumors treated with VEGF receptor tyrosine kinase inhibitors: a critical literature review and meta analysis

✍ Abdel-Rahman, Omar ;Fouad, Mona 📂 Article 📅 2014 🏛 Expert Reviews 🌐 English ⚖ 473 KB